Thomas Mazumder

Statistics

Publications

Citations

233

H-Index

Active since

2023

Affiliations

University of California, San Francisco(Current)

Innovative Genomics Institute

University of California, Berkeley

Gladstone Institutes

Parker Institute for Cancer Immunotherapy

Thomas Mazumder is an author at University of California, San Francisco specializing in immune cell engineering, primary cells, and genetic engineering.

ORCID

Publications per year

2023–2025

Publications

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

Connor A. Tsuchida, Nadav Brandes, Raymund Bueno et al. · Cell · 2023 · 185 citations · Full text

Life Sciences, Genetics, Immunology +17

Mitigation of Chromosome Loss in Clinical CRISPR-Cas9-Engineered T Cells

Connor A. Tsuchida, Nadav Brandes, Raymund Bueno et al. · SSRN Electronic Journal · 2023 · 18 citations · Full text

Life Sciences, Genetics, Immunology +17

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

Connor A. Tsuchida, Nadav Brandes, Raymund Bueno et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 16 citations · Full text

Life Sciences, Genetics, Immunology +17

SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci

Christopher Chang, Vivasvan S. Vykunta, Jae Hyun J. Lee et al. · Nature Biotechnology · 2025 · 14 citations · Full text

Life Sciences, Bioengineering, Biotechnology +17

1–4 of 4